LEXX Lexaria Bioscience Corporation

0.0299 (3.08%)
Sep 29 2023 - Closed
Delayed by 15 minutes

Register Free for Streaming Quotes & Tools

Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.


Draw Mode:

Volume 50,196
Bid Price 0.79
Ask Price 1.12
News -
Day High 0.9999


52 Week Range


Day Low 0.8502
Company Name Stock Ticker Symbol Market Type
Lexaria Bioscience Corporation LEXX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0299 3.08% 0.9999 18:00:04
Open Price Low Price High Price Close Price Prev Close
0.8502 0.8502 0.9999 0.9999 0.97
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
149 50,196 $ 0.9314662 $ 46,756 - 0.6488 - 3.5953
Last Trade Time Type Quantity Stock Price Currency
16:00:00 97 $ 0.9902 USD

Lexaria Bioscience Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
8.09M 8.09M - 384k -4.23M 0.00 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Lexaria Bioscience News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No LEXX Message Board. Create One! See More Posts on LEXX Message Board See More Message Board Posts

Historical LEXX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.9051.000.85020.948722234,8910.094910.49%
1 Month1.021.05680.8440.92727650,929-0.0201-1.97%
3 Months0.721.19710.720.913204792,1300.279938.88%
6 Months2.5872.780.64880.8924465120,127-1.59-61.35%
1 Year2.483.59530.64881.1570,390-1.48-59.68%
3 Years4.0512.500.64885.67364,492-3.05-75.31%
5 Years4.0512.500.64885.67364,492-3.05-75.31%

Lexaria Bioscience Description

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH has the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio.
Your Recent History
Lexaria Bi..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now